Pfizer, Sandoz Agree To End Caduet Patent Fight
A Delaware federal judge on Monday dismissed consolidated patent litigation between Pfizer Inc. and Sandoz Inc. over Pfizer's blood pressure and cholesterol drug Caduet, after they agreed to drop the dispute....To view the full article, register now.
Already a subscriber? Click here to view full article